InChI=1S/C26H41N3O5/c1- 17(2) 12- 21(15- 30) 27- 24(31) 22(13- 18(3) 4) 28- 25(32) 23(14- 19(5) 6) 29- 26(33) 34- 16- 20- 10- 8- 7- 9- 11- 20/h7- 11,15,17- 19,21- 23H,12- 14,16H2,1- 6H3,(H,27,31) (H,28,32) (H,29,33) /t21- ,22- ,23- /m0/s1 |
TZYWCYJVHRLUCT-VABKMULXSA-N |
C([C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1)=O)=O)(=O)[H] |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
proteasome inhibitor
A drug that blocks the action of proteasomes, cellular complexes that break down proteins.
|
|
N- [(benzyloxy)carbonyl]- L- leucyl- N- [(2S)- 4- methyl- 1- oxopentan- 2- yl]- L- leucinamide
|
(S)- N- ((phenylmethoxy)carbonyl)- L- leucyl- N- (1- formyl- 3- methylbutyl)- L- leucinamide
|
ChemIDplus
|
benzyloxycarbonyl-leu-leu-leu-aldehyde
|
ChemIDplus
|
benzyloxycarbonyl-leucyl-leucyl-leucinal
|
ChemIDplus
|
benzyloxycarbonylleucyl-leucyl-leucine aldehyde
|
ChemIDplus
|
carbobenzoxy-Leu-Leu-leucinal
|
ChEBI
|
carbobenzoxy-leucyl-leucyl-leucinal
|
ChemIDplus
|
carbobenzoxyl-leucinyl-leucinyl-leucinal-H
|
ChemIDplus
|
Cbz-L-Leu-L-Leu-L-Leu-CHO
|
ChEBI
|
Cbz-L-Leu-L-Leu-L-Leu-H
|
ChEBI
|
Cbz-Leu-Leu-Leu-CHO
|
ChEBI
|
Cbz-Leu-Leu-Leu-H
|
ChEBI
|
Cbz-Leu-Leu-Leucinal
|
ChEBI
|
MG 132
|
ChemIDplus
|
MG-132
|
ChemIDplus
|
Z-Leu-Leu-Leu-al
|
ChemIDplus
|
Z-Leu-Leu-Leu-CHO
|
ChEBI
|
Z-Leu-Leu-Leu-H
|
ChEBI
|
Z-Leu-Leu-Leucinal
|
ChemIDplus
|
Z-LLL-CHO
|
ChEBI
|
Z-LLL-H
|
ChEBI
|
Z-LLLal
|
ChemIDplus
|
ZLLL-CHO
|
ChemIDplus
|
ZLLLal
|
ChemIDplus
|